Indonesia has suspended the sale of all syrup and liquid medication in the wake of the deaths of 100 children, said reports.
This year, up to 99 kids died after taking syrup medicines that had components associated with severe kidney problems (AKI).
According to the BBC, 200 cases of AKI in kids, most of whom were under five years old, were recorded by Indonesian health officials on Thursday.
The report claimed that Indonesian authorities had only temporarily outlawed the sale and prescription of all syrup and liquid medicines, not yet identifying the specific brands or varieties of syrup medications connected to sick children.
According to the BBC report, it is unclear whether the medication was imported or made in the country.
Nearly 70 children’s deaths in The Gambia have been connected to four cough syrups, prompting the World Health Organization (WHO) to issue a global alert.
The deaths of the kids in The Gambia were linked to four cough syrups made in India.
The cough syrup produced by New Delhi-based Indian pharmaceutical company Maiden Pharmaceuticals is not sold in India but is being exported.
The Central Drugs Standard Control Organization (CDSO) has opened an immediate investigation into the situation in response to the WHO alert.
